Literature DB >> 21645497

Differential dephosphorylation of the protein kinase C-zeta (PKCζ) in an integrin αIIbβ3-dependent manner in platelets.

Azad Mayanglambam1, Dheeraj Bhavanasi, K Vinod Vijayan, Satya P Kunapuli.   

Abstract

Protein kinase C-zeta (PKCζ), an atypical isoform of the PKC family of protein serine/threonine kinases, is expressed in human platelets. However, the mechanisms of its activation and the regulation of its activity in platelets are not known. We have found that under basal resting conditions, PKCζ has a high phosphorylation status at the activation loop threonine 410 (T410) and the turn motif (autophosphorylation site) threonine 560 (T560), both of which have been shown to be important for its catalytic activity. After stimulation with agonist under stirring conditions, the T410 residue was dephosphorylated in a time- and concentration-dependent manner, while the T560 phosphorylation remained unaffected. The T410 dephosphorylation could be significantly prevented by blocking the binding of fibrinogen to integrin αIIbβ3 with an antagonist, SC-57101; or by okadaic acid used at concentrations that inhibits protein serine/threonine phosphatases PP1 and PP2A in vitro. The dephosphorylation of T410 residue on PKCζ was also observed in PP1cγ null murine platelets after agonist stimulation, suggesting that other isoforms of PP1c or another phosphatase could be responsible for this dephosphorylation event. We conclude that human platelets express PKCζ, and it may be constitutively phosphorylated at the activation loop threonine 410 and the turn motif threonine 560 under basal resting conditions, which are differentially dephosphorylated by outside-in signaling. This differential dephosphorylation of PKCζ might be an important regulatory mechanism for platelet functional responses.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21645497      PMCID: PMC3148309          DOI: 10.1016/j.bcp.2011.05.022

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  37 in total

1.  Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway.

Authors:  M Leitges; L Sanz; P Martin; A Duran; U Braun; J F García; F Camacho; M T Diaz-Meco; P D Rennert; J Moscat
Journal:  Mol Cell       Date:  2001-10       Impact factor: 17.970

2.  A mammalian PAR-3-PAR-6 complex implicated in Cdc42/Rac1 and aPKC signalling and cell polarity.

Authors:  D Lin; A S Edwards; J P Fawcett; G Mbamalu; J D Scott; T Pawson
Journal:  Nat Cell Biol       Date:  2000-08       Impact factor: 28.824

3.  Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation.

Authors:  Todd M Quinton; Soochong Kim; Carol Dangelmaier; Robert T Dorsam; Jianguo Jin; James L Daniel; Satya P Kunapuli
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

4.  The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathway.

Authors:  L Sanz; M T Diaz-Meco; H Nakano; J Moscat
Journal:  EMBO J       Date:  2000-04-03       Impact factor: 11.598

5.  Protein kinase C zeta plays a central role in activation of the p42/44 mitogen-activated protein kinase by endotoxin in alveolar macrophages.

Authors:  M M Monick; A B Carter; D M Flaherty; M W Peterson; G W Hunninghake
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

6.  Role of zeta PKC in B-cell signaling and function.

Authors:  Pilar Martin; Angeles Duran; Susana Minguet; María-Luisa Gaspar; Maria-Teresa Diaz-Meco; Paul Rennert; Michael Leitges; Jorge Moscat
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

7.  Osteopontin inhibits interleukin-1beta-stimulated increases in matrix metalloproteinase activity in adult rat cardiac fibroblasts: role of protein kinase C-zeta.

Authors:  Zhonglin Xie; Mahipal Singh; Deborah A Siwik; William L Joyner; Krishna Singh
Journal:  J Biol Chem       Date:  2003-09-18       Impact factor: 5.157

8.  Caspase processing activates atypical protein kinase C zeta by relieving autoinhibition and destabilizes the protein.

Authors:  Lucinda Smith; Zhi Wang; Jeffrey B Smith
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

Review 9.  Protein kinase Czeta (PKCzeta): activation mechanisms and cellular functions.

Authors:  Takaaki Hirai; Kazuhiro Chida
Journal:  J Biochem       Date:  2003-01       Impact factor: 3.387

10.  Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity.

Authors:  Pramod P Naranatt; Shaw M Akula; Christopher A Zien; Harinivas H Krishnan; Bala Chandran
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

View more
  3 in total

1.  Attenuation of amyloid-β generation by atypical protein kinase C-mediated phosphorylation of engulfment adaptor PTB domain containing 1 threonine 35.

Authors:  Dennis Dik-Long Chau; Kristen Wing-Yu Yung; William Wai-Lun Chan; Ying An; Yan Hao; Ho-Yin Edwin Chan; Jacky Chi-Ki Ngo; Kwok-Fai Lau
Journal:  FASEB J       Date:  2019-08-05       Impact factor: 5.191

Review 2.  Platelet signaling: a complex interplay between inhibitory and activatory networks.

Authors:  A P Bye; A J Unsworth; J M Gibbins
Journal:  J Thromb Haemost       Date:  2016-04-09       Impact factor: 5.824

3.  Thrombocytopenia-associated mutations in Ser/Thr kinase MASTL deregulate actin cytoskeletal dynamics in platelets.

Authors:  Begoña Hurtado; Marianna Trakala; Pilar Ximénez-Embún; Aicha El Bakkali; David Partida; Belén Sanz-Castillo; Mónica Álvarez-Fernández; María Maroto; Ruth Sánchez-Martínez; Lola Martínez; Javier Muñoz; Pablo García de Frutos; Marcos Malumbres
Journal:  J Clin Invest       Date:  2018-10-29       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.